Featured Content

More News

Sector News

More News

News and Analysis

  • Come Join Our Commuity We are offering discounted subscription plans to join BioMedReports.com for a limited time.
  • Q&A with LabStyle Innovations Exec VP, Todd Durniak Recently, LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, announced it had closed a round of funding totaling approximately $2.5 million. According to management, the monies will be used to support the global rollout and initial U.S. commercial launch of their flagship product Dario™ for working capital purposes.
More News


BioMedReports Actinium Issues Letter to Shareholders Outlining Recent and Expected Milestones: https://t.co/3TfjhrwAzz $ATNM
BioMedReports Got diabetes? Meet the new glucose monitoring gadget that’s super-easy and plugs right into your smartphone: https://t.co/YyU6y4cc9U $DRIO
BioMedReports “The Next Generation of Biologicals will be Cell-based” https://t.co/PKrsRyARoy $PSTI

RSS Subscription